Beumer, Jan H <br/><br/>
Disposition of imatinib and its metabolite CGP74588 in a patient with chronic myelogenous leukemia and short-bowel syndrome.  [electronic resource] 

 -  Pharmacotherapy  Jul 2006 
 - 903-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0277-0008 
<br/><br/><label>Standard No.: </label>10.1592/phco.26.7.903  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--blood<br/>Benzamides<br/>Female<br/>Humans<br/>Imatinib Mesylate<br/>Jejunostomy<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Middle Aged<br/>Piperazines--blood<br/>Pyrimidines--blood<br/>Short Bowel Syndrome--metabolism